相关实验视频

Updated: Jan 14, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

最近批准对未来阿尔茨海默病临床发展的影响:对组合试验的统计考虑

Samuel P Dickson¹, Craig Mallinckrodt¹, Aaron H Burstein²

¹Pentara Corporation, Salt Lake City, UT, USA.

The journal of prevention of Alzheimer's disease

|October 27, 2025

概括

对阿尔茨海默病 (AD) 疗法与抗粉样类单克隆抗体 (mABs) 结合的临床试验设计复杂. 协同效应需要比对抗效应更小的样本大小,影响试验成本和可行性.

科学领域:

神经科学是一个神经科学.
临床试验临床试验
药理学药理学是指药理学的学科.

背景情况:

阿尔茨海默病 (AD) 研究正在进入一个新的阶段,已批准的抗粉样蛋白单克隆抗体 (mABs).
试验性疗法可能与mAB联合使用,导致潜在的相互作用,如对抗性或协同作用.
了解这些相互作用对于有效的临床试验设计至关重要.

研究的目的:

评估临床试验设计场景,用于与抗粉样蛋白 mABs一起使用的试验性疗法.
为各种试验设计和患者群体计算样本大小 (二级预防,早期AD,轻度至中度AD).
分析治疗相互作用 (附加性,对抗性,协同性) 对研究要求的影响.

主要方法:

考虑了三种试验设计:对mAB的2臂补充,2臂组合与双安慰剂,以及4臂全因数.
针对不同AD阶段的1年,18个月和2年研究的计算样本大小.
模拟了添加剂,对抗性和协同作用的治疗效应.

主要成果:

治疗相互作用显著影响试验功率和设计.
与协同效应相比,对抗效应可能需要增加两倍的样本大小.
与2臂组合研究相比,4臂因数设计需要大约增加10倍的样本大小.

结论:

对阿尔茨海默病治疗方法的附加试验是复杂而昂贵的,受治疗相互作用的影响.
协同治疗更容易研究,因为与mABs的作用机制相辅相成.
在附加试验中,症状治疗可能需要比疾病修饰性治疗更少的患者.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.组合试验,附加试验,统计考虑.

更多相关视频

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...